Carerx Corp Stock Performance
| CRRX Stock | CAD 1.89 0.01 0.53% |
CareRx Corp has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.12, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning CareRx Corp are expected to decrease at a much lower rate. During the bear market, CareRx Corp is likely to outperform the market. CareRx Corp right now shows a risk of 2.46%. Please confirm CareRx Corp value at risk, skewness, and the relationship between the maximum drawdown and potential upside , to decide if CareRx Corp will be following its price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in CareRx Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, CareRx Corp is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Last Split Factor 1:20 | Dividend Date 2020-06-25 | Last Split Date 2020-06-25 |
1 | CareRx Unveils High-Tech Pharmacy in British Columbia - TipRanks | 10/01/2024 |
2 | CareRx Corp Q3 2024 Earnings Call Highlights Navigating Growth Amid Revenue Challenges - Yahoo Finance UK | 11/08/2024 |
| Begin Period Cash Flow | 29.1 M |
CareRx |
CareRx Corp Relative Risk vs. Return Landscape
If you would invest 182.00 in CareRx Corp on September 2, 2024 and sell it today you would earn a total of 7.00 from holding CareRx Corp or generate 3.85% return on investment over 90 days. CareRx Corp is generating 0.0882% of daily returns and assumes 2.4612% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than CareRx, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
CareRx Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CareRx Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CareRx Corp, and traders can use it to determine the average amount a CareRx Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0359
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | CRRX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.46 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average CareRx Corp is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CareRx Corp by adding it to a well-diversified portfolio.
CareRx Corp Fundamentals Growth
CareRx Stock prices reflect investors' perceptions of the future prospects and financial health of CareRx Corp, and CareRx Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CareRx Stock performance.
| Return On Equity | -0.075 | ||||
| Return On Asset | 0.0218 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 200.23 M | ||||
| Shares Outstanding | 63.49 M | ||||
| Price To Book | 1.50 X | ||||
| Price To Sales | 0.33 X | ||||
| Revenue | 370.75 M | ||||
| Gross Profit | 109.93 M | ||||
| EBITDA | 27.2 M | ||||
| Net Income | (5.41 M) | ||||
| Cash And Equivalents | 28.37 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 97.52 M | ||||
| Debt To Equity | 2.35 % | ||||
| Current Ratio | 1.69 X | ||||
| Book Value Per Share | 1.33 X | ||||
| Cash Flow From Operations | 16.17 M | ||||
| Earnings Per Share | (0.10) X | ||||
| Market Capitalization | 119.99 M | ||||
| Total Asset | 231.89 M | ||||
| Retained Earnings | (282.69 M) | ||||
| Working Capital | 2.96 M | ||||
About CareRx Corp Performance
By examining CareRx Corp's fundamental ratios, stakeholders can obtain critical insights into CareRx Corp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that CareRx Corp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 25.08 | 18.78 | |
| Return On Tangible Assets | (0.05) | (0.05) | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.07) | (0.07) |
Things to note about CareRx Corp performance evaluation
Checking the ongoing alerts about CareRx Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CareRx Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CareRx Corp may become a speculative penny stock | |
| CareRx Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 370.75 M. Net Loss for the year was (5.41 M) with profit before overhead, payroll, taxes, and interest of 109.93 M. | |
| Latest headline from news.google.com: CareRx Corp Q3 2024 Earnings Call Highlights Navigating Growth Amid Revenue Challenges - Yahoo Finance UK |
- Analyzing CareRx Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CareRx Corp's stock is overvalued or undervalued compared to its peers.
- Examining CareRx Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CareRx Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CareRx Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CareRx Corp's stock. These opinions can provide insight into CareRx Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in CareRx Stock
CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.